PUMA BIOTECHNOLOGY, INC. Cost of Goods Sold (Deprecated 2018-01-31)
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Cost of Goods Sold (Deprecated 2018-01-31) of $6.38 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-10
- PUMA BIOTECHNOLOGY, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $6.38M.
- PUMA BIOTECHNOLOGY, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $4.05M.
- PUMA BIOTECHNOLOGY, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.53M.
- PUMA BIOTECHNOLOGY, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $5.57M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $6.38M 10-Q · filed 2018-05-10 | $10.43M derived: sum of 2 quarters · filed 2018-05-10 | $11.96M derived: sum of 3 quarters · filed 2018-05-10 | |
| 2017-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $5.57M derived: sum of 2 quarters · filed 2018-03-09 | $5.57M 10-K · filed 2018-03-09 | |
| 2017-09-30 | $1.53M 10-Q · filed 2017-11-09 | $1.53M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |